Novavax (NVAX) saw its stock price surge by 11.52% during Wednesday's intraday trading session, reflecting strong investor interest in the biotech company.
The rally was accompanied by unusually high call volume, with 15,177 calls traded—three times the expected volume—and implied volatility rising nearly 8 points to 71.12%. This bullish option activity suggests traders are betting on further upside for Novavax in the near term.